The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure.

Source:http://linkedlifedata.com/resource/pubmed/id/10675760

J. Immunol. Methods 2000 Feb 21 235 1-2 81-90

Download in:

View as

General Info

PMID
10675760